HEM Pharma Inc. (KOSDAQ:376270)
72,500
+7,600 (11.71%)
At close: Mar 5, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 535.01 billion as of March 6, 2026. Its market cap has increased by 346.78% in one year.
Market Cap
535.01B
Enterprise Value
542.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
72,500.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 535.01B, an increase of 368.58%. That is a compound annual growth rate of 218.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 535.01B | 63.37% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 569.59B |
| Samyang Biopharm | 689.31B |
| CellBion | 359.28B |
| Myung In Pharmaceutical LTD. | 905.20B |
| DAE HWA Pharmaceutical | 250.31B |
| NOVAREX | 225.53B |
| Vivozon Pharmaceutical | 196.71B |
| Organoidsciences | 187.36B |